Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Klinikum

FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz

Forschungsprojekte
Ergebnisse pro Seite:  10

2014 - 2015

RLX030A
  • Univ.-Prof. Dr. Tommaso

2014 - 2018

Energy metabolism in ovarian cancer
  • Dr. Marco Johannes,
  • PD Dr. Stefan,
  • Univ.-Prof. Dr. Wolfgang,
  • Univ.-Prof. Dr. Marcus,
  • Univ.-Prof. Dr. Annette

2014 - 2019

Clinical phase III trial to compare Treosulfan-based conditioning therapy with Busulfan-based reduced-intensity conditioning (RIC) prior to allogeneic haematopoietic stem cell transplantation in patients with AML or MDS considered ineligible to standard conditioning regimens (#542)
  • Dr. Eva Maria

2014 - 2016

COMBO DTS.de Register
  • Univ.-Prof. Dr. Tommaso

2014 - 2017

A Randomized, Open-label, Phase 3 Study of Carfilzomib, Melphalan, and Prednisone versus Bortezomib, Melphalan, and Prednisone in Transplant-ineligible Patients with Newly Diagnosed Multiple Myeloma (#516)
  • PD Dr. Markus

2014 - 2016

Direct Flow Discover Register
  • Univ.-Prof. Dr. Ulrich

2014 - 2019

Pomalidomid/Dexamethason und remissionsabhängig Cyclophosphamid bei Myelom-Rezidiv (#550)
  • PD Dr. Markus

2014 - 2021

A randomized, double-blind, placebo-controlled phase 3 study of the Bruton’s Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in combination with either Bendamustine and Rituximab (BR) or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in subjects with previously treated indolent Non-Hodgkin Lymphoma (iNHL) (#551)
  • Univ.-Prof. Dr. Georg

2014 - 2017

Allo-Protect (#552)
  • Dr. Eva Maria

2014 - 2019

WINGS (#572)
  • Dr. Charis